Managing hepatitis B reactivation in renal transplant recipients: a 12-year review with emphasis on early detection and early use of lamivudine.
Tsai
M K
MK
Department of Surgery, National Taiwan University Hospital, Taipei, Taiwan.
Lai
M Y
MY
Hu
R H
RH
Lee
C J
CJ
Lee
P H
PH
D000328:Adult; D000998:Antiviral Agents / Q000627:therapeutic use*; D002353:Carrier State; D004359:Drug Therapy, Combination; D005260:Female; D006509:Hepatitis B / Q000175:diagnosis / Q000188:drug therapy* / Q000401:mortality / Q000503:physiopathology*; D006513:Hepatitis B e Antigens / Q000097:blood; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D016030:Kidney Transplantation; D019259:Lamivudine / Q000627:therapeutic use*; D008111:Liver Function Tests; D008297:Male; D008875:Middle Aged; D011183:Postoperative Complications / Q000821:virology; D012189:Retrospective Studies; D016019:Survival Analysis; D016896:Treatment Outcome
D000998:Antiviral Agents; D006513:Hepatitis B e Antigens; D007166:Immunosuppressive Agents; D019259:Lamivudine